ALKS EBITDA | Alkermes plc.

Alkermes plc. (ALKS) EBITDA

2026-06-30: Basis Reported; EBITDA $48.63M*; Operating income $18.35M; Depreciation and amortization $30.28M*.
2026-03-31: Basis Reported; EBITDA -$28.85M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $61.95M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $97.16M*; Operating income $89.08M; Depreciation and amortization $8.08M*.

Complete source-backed ebitda history.

Available history: 2010-03-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$48.63M*	$18.35M	$30.28M*	$496.01M	9.80%*	$8.15M*	$145.18M*	$98.11M	$112.92M	$217.63M	-$2.38M
2026-03-31	Reported	-$28.85M	(m)	(m)	(m)	-7.34%	$4.09M	-$165.74M	$61.58M	$103.34M	$264.59M	$4.55M
2025-12-31	Reported	$61.95M	(m)	(m)	(m)	16.11%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$97.16M*	$89.08M	$8.08M*	$394.19M	24.65%*	$17.31M*	$101.67M*	$51.59M	$81.74M	$171.77M	$17.98M
2025-06-30	Reported	$100.80M*	$92.98M	$7.82M*	$390.66M	25.80%*	$13.02M*	$150.20M*	$49.46M	$77.37M	$170.85M	$17.74M
2025-03-31	Reported	$21.21M	(m)	(m)	(m)	6.92%	$10.11M	$98.81M	$49.20M	$71.82M	$171.70M	$3.02M
2024-12-31	Reported	$169.54M	(m)	(m)	(m)	39.43%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$111.73M*	$104.76M	$6.97M*	$378.14M	29.55%*	$8.26M*	$81.59M*	$63.10M	$59.89M	$150.38M	$17.43M
2024-06-30	Reported	$116.54M*	$109.88M	$6.66M*	$399.13M	29.20%*	$7.11M*	$146.03M*	$61.47M	$59.65M	$168.11M	$22.06M
2024-03-31	Reported	$51.37M	(m)	(m)	(m)	14.66%	$8.34M	$21.11M	$58.64M	$67.61M	$179.75M	$7.96M
2023-12-31	Reported	$73.17M	(m)	(m)	(m)	19.38%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$107.86M*	$89.19M	$18.66M*	$380.94M	28.31%*	$14.45M*	$99.71M*	$61.50M	$64.88M	$156.37M	$1.15M
2023-06-30	Reported	$300.28M*	$281.27M	$19.01M*	$617.40M	48.64%*	$9.71M*	$215.71M*	$63.25M	$68.22M	$195.76M	$2.73M
2023-03-31	Reported	$7.74M	(m)	(m)	(m)	2.69%	$6.86M	-$21.30M	$58.16M	$63.77M	$167.83M	$717.00K
2022-12-31	Reported	$135.27M	(m)	(m)	(m)	44.40%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$41.04M*	-$60.64M	$19.60M*	$252.36M	-16.26%*	$10.47M*	$625.00K*	$50.63M	$100.43M	$152.78M	-$3.39M
2022-06-30	Reported	-$15.07M*	-$34.46M	$19.39M*	$276.22M	-5.45%*	$9.96M*	-$2.31M*	$58.36M	$92.87M	$150.38M	-$3.11M
2022-03-31	Reported	-$7.39M	(m)	(m)	(m)	-2.65%	$7.79M	$21.68M	$55.16M	$95.95M	$145.05M	-$9.10M
2021-12-31	Reported	$150.56M	(m)	(m)	(m)	46.40%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$268.00K*	-$19.66M	$19.39M*	$294.14M	-0.09%*	$4.81M*	$82.78M*	$49.56M	$118.41M	$136.21M	$2.45M
2021-06-30	Reported	$22.90M*	$4.42M	$18.48M*	$303.72M	7.54%*	$6.56M*	$33.06M*	$53.12M	$97.47M	$139.19M	$3.29M
2021-03-31	Reported	$3.21M	(m)	(m)	(m)	1.28%	$7.99M	-$45.15M	$41.02M	$92.27M	$125.17M	$3.77M
2020-12-31	Reported	-$10.4M	(m)	(m)	(m)	-3.71%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	$9.91M*	-$10.67M	$20.58M*	$265.01M	3.74%*	$6.41M*	$60.20M*	$43.13M	$94.98M	$127.65M	$2.33M
2020-06-30	Reported	-$13.32M*	-$33.66M	$20.34M*	$247.53M	-5.38%*	$10.57M*	-$4.43M*	$45.05M	$94.22M	$132.03M	$3.67M
2020-03-31	Reported	-$16.76M	(m)	(m)	(m)	-6.81%	$19.80M	-$40.27M	$47.21M	$93.28M	$133.37M	$7.33M
2019-12-31	Reported	$10.58M	(m)	(m)	(m)	2.56%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$33.28M*	-$53.62M	$20.34M*	$255.24M	-13.04%*	$19.43M*	$30.97M*	$42.32M	$107.67M	$148.70M	-$983.00K
2019-06-30	Reported	-$16.01M*	-$35.92M	$19.91M*	$279.87M	-5.72%*	$15.90M*	-$23.18M*	$46.22M	$104.44M	$155.07M	$1.60M
2019-03-31	Reported	-$56.36M	(m)	(m)	(m)	-25.26%	$23.64M	$22.21M	$45.36M	$102.57M	$141.22M	-$3.85M
2018-12-31	Reported	$25.92M	(m)	(m)	(m)	8.21%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$10.89M*	-$37.16M	$26.27M*	$248.72M	-4.38%*	$16.42M*	$33.48M*	$39.41M	$101.27M	$128.78M	$611.00K
2018-06-30	Reported	$25.67M*	-$102.00K	$25.77M*	$304.64M	8.43%*	$16.93M*	$32.13M*	$43.42M	$106.82M	$138.26M	$8.20M
2018-03-31	Reported	-$36.17M	(m)	(m)	(m)	-16.06%	$18.48M	-$26.84M	$44.48M	$108.35M	$118.15M	-$4.49M
2017-12-31	Reported	$31.05M	(m)	(m)	(m)	11.28%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$13.32M*	-$38.36M	$25.04M*	$217.38M	-6.13%*	$12.83M*	$19.48M*	$36.05M	$104.41M	$99.63M	$486.00K
2017-06-30	Reported	-$20.00M*	-$44.51M	$24.51M*	$218.84M	-9.14%*	$11.27M*	-$22.45M*	$39.77M	$99.15M	$108.95M	-$2.68M
2017-03-31	Reported	-$47.11M	(m)	(m)	(m)	-24.56%	$9.38M	-$13.75M	(m)	$104.83M	$102.10M	-$3.71M
2016-12-31	Reported	$1.11M	(m)	(m)	(m)	0.52%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$37.31M*	-$61.13M	$23.82M*	(m)	(m)	$11.51M*	$14.73M*	(m)	$99.44M	$91.14M	-$2.65M
2016-06-30	Reported	-$24.03M*	-$47.12M	$23.08M*	(m)	(m)	$10.27M*	(m)	(m)	$97.01M	$96.12M	-$520.00K
2016-03-31	Reported	-$54.18M	(m)	(m)	(m)	-34.56%	$12.01M	(m)	(m)	$101.07M	$89.72M	$404.00K
2015-12-31	Reported	-$45.28M	(m)	(m)	(m)	-27.76%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$56.71M*	-$77.42M	$20.71M*	(m)	(m)	$11.97M*	(m)	(m)	$92.56M	$89.50M	$3.00M
2015-06-30	Reported	-$31.90M*	-$52.52M	$20.62M*	(m)	(m)	$14.04M*	(m)	(m)	$87.88M	$71.54M	$3.06M
2015-03-31	Reported	-$4.82M	(m)	(m)	(m)	-2.99%	$10.71M	(m)	(m)	$70.28M	$63.05M	$510.00K
2014-12-31	Reported	$9.68M	(m)	(m)	(m)	5.53%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$7.50M*	-$32.74M	$25.23M*	(m)	(m)	$8.89M*	(m)	(m)	$78.26M	$51.89M	$3.52M
2014-06-30	Reported	$2.11M*	-$22.82M	$24.93M*	(m)	(m)	$5.75M*	(m)	(m)	$67.21M	$50.66M	-$1.52M
2014-03-31	Reported	$6.66M	(m)	(m)	(m)	5.11%	$5.68M	(m)	(m)	$52.14M	$42.55M	$3.77M
2013-09-30	Reported	(m)	-$3.88M	(m)	(m)	(m)	(m)	(m)	(m)	$45.95M	$39.45M	$233.00K
2013-06-30	Reported	$37.26M	(m)	(m)	(m)	26.87%	$3.63M	(m)	(m)	$33.46M	$32.93M	$2.72M
2013-03-31	Reported	$37.31M	(m)	(m)	(m)	22.83%	$8.26M	(m)	(m)	$35.80M	$34.68M	$4.87M
2012-12-31	Reported	$43.86M*	$25.26M	$18.60M*	(m)	(m)	$2.75M*	(m)	(m)	$31.32M	$29.87M	$4.41M
2012-09-30	Reported	$24.23M*	$5.42M	$18.81M*	(m)	(m)	$4.47M*	(m)	(m)	$35.09M	$31.43M	$422.00K
2012-06-30	Reported	$50.16M	(m)	(m)	(m)	32.95%	$6.73M	(m)	(m)	$37.81M	$29.78M	$764.00K
2012-03-31	Reported	-$37.04M	(m)	(m)	(m)	-28.39%	(m)	(m)	(m)	(m)	(m)	(m)
2011-12-31	Reported	$15.91M*	-$4.97M	$20.87M*	(m)	(m)	$5.21M*	-$2.21M*	(m)	$40.49M	$35.47M	$98.00K
2011-09-30	Reported	-$7.29M*	-$11.76M	$4.47M*	(m)	(m)	$2.73M*	(m)	(m)	$28.16M	$36.23M	$3.65M
2011-06-30	Reported	-$11.98M	(m)	(m)	(m)	-19.35%	$924.00K	(m)	(m)	$28.05M	$31.50M	-$54.00K
2010-12-31	Reported	(m)	-$11.91M	(m)	(m)	(m)	$1.31M*	$12.90M*	(m)	$22.50M	$20.52M	$41.00K
2010-09-30	Reported	(m)	-$7.03M	(m)	(m)	(m)	(m)	(m)	(m)	$23.93M	$18.44M	-$943.00K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$281.12M	(m)	(m)	(m)	19.05%	$40.42M	$520.75M	$196.46M	$323.96M	$701.52M	$49.79M
2024-12-31	Reported	$449.17M	(m)	(m)	(m)	28.84%	$33.48M	$439.12M	$245.33M	$245.33M	$645.24M	$71.61M
2023-12-31	Reported	$489.05M	(m)	(m)	(m)	29.40%	$48.05M	$401.35M	$253.04M	$270.81M	$689.75M	-$97.64M
2022-12-31	Reported	$71.77M	(m)	(m)	(m)	6.46%	$38.26M	$21.04M	$218.07M	$272.70M	$590.75M	$2.02M
2021-12-31	Reported	$176.4M	(m)	(m)	(m)	15.03%	$28.02M	$101.72M	$197.32M	$290.92M	$549.61M	$11.33M
2020-12-31	Reported	-$30.57M	(m)	(m)	(m)	-2.94%	$42.22M	$82.84M	$178.32M	$394.59M	$538.83M	$14.32M
2019-12-31	Reported	-$95.07M	(m)	(m)	(m)	-8.12%	$90.94M	$72.08M	$180.38M	$512.83M	$599.45M	-$436.00K
2018-12-31	Reported	$4.53M	(m)	(m)	(m)	0.41%	$69.43M	$99.28M	$176.42M	$425.41M	$526.41M	$12.34M
2017-12-31	Reported	-$49.38M	(m)	(m)	(m)	-5.47%	$51.30M	$19.19M	$154.75M	$412.89M	$421.58M	$14.67M
2016-12-31	Reported	-$114.41M	(m)	(m)	(m)	-15.34%	$43.66M	-$63.80M	$132.12M	$387.15M	$374.13M	-$5.94M
2015-12-31	Reported	-$138.71M	(m)	(m)	(m)	-22.08%	$52.88M	-$40.36M	(m)	$344.40M	$311.56M	$3.16M
2014-12-31	Reported	$10.94M	(m)	(m)	(m)	1.77%	$33.65M	(m)	(m)	$272.04M	$199.91M	$16.03M
2013-12-31	Reported	(m)	$34.48M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	-$7.38M
2013-09-30	Rolling	(m)	$53.90M*	(m)	(m)	(m)	(m)	(m)	(m)	$146.53M*	$136.93M*	$12.22M*
2013-06-30	Rolling	$142.66M*	$63.20M*	$79.46M*	(m)	(m)	$19.11M*	(m)	(m)	$135.67M*	$128.91M*	$12.41M*
2013-03-31	Reported	$155.56M	(m)	(m)	(m)	27.03%	$22.22M	(m)	(m)	$140.01M	$125.76M	$10.46M
2013-03-31	Rolling	$155.56M*	$81.81M*	$73.75M*	(m)	(m)	$22.22M*	(m)	(m)	$140.01M*	$125.76M*	$10.46M*
2012-03-31	Reported	-$40.4M	(m)	(m)	(m)	-10.36%	$16.99M	-$2.48M	(m)	$141.89M	$137.63M	-$714.00K
2011-03-31	Reported	-$36.98M	(m)	(m)	(m)	-19.81%	$9.40M	-$5.91M	(m)	$97.24M	$82.85M	-$951.00K
2010-03-31	Reported	-$18.01M	(m)	(m)	(m)	-10.10%	$15.79M	-$12.25M	(m)	$95.36M	$76.51M	-$5.08M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
RHYTHM PHARMACEUTICALS, INC. (RYTM)	United States	$6.771B	-37.20
IONIS PHARMACEUTICALS INC (IONS)	United States	$7.277B	-23.25
Liquidia Corp (LQDA)	United States	$6.347B	51.23
Amneal Pharmaceuticals, Inc. (AMRX)		$6.326B	25.62
Spyre Therapeutics, Inc. (SYRE)	United States	$7.685B	-43.69
Structure Therapeutics Inc. (GPCR)	United States	$7.710B	-53.41
Praxis Precision Medicines, Inc. (PRAX)	United States	$7.884B	-27.60
Mirum Pharmaceuticals, Inc. (MIRM)	United States	$5.798B	-8.81
Travere Therapeutics, Inc. (TVTX)	United States	$5.712B	-123.10
Oruka Therapeutics, Inc. (ORKA)	United States	$5.663B	-43.76